Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Could LSE:FUM Futura Medical Plc Be the UK Healthcare Stock to Watch After Today's 15.00% Slide?

Futura Medical Plc came under significant selling pressure during Thursday's trading session as investors reduced exposure to higher-risk healthcare growth companies.

Ankur Sharma | 16 July 2026

Why Did Futura Medical plc (LSE:FUM) Surge 5.00% Today? Is This UK Healthcare Stock Regaining Momentum After Commercial Progress?

Futura Medical plc attracted increased investor attention after its shares advanced5.00%during trading on16 July 2026.

Ankur Sharma | 16 July 2026

Why Did Genedrive plc (LSE:GDR) Rise 4.76% Today? Is This UK Molecular Diagnostics Stock Building Fresh Momentum?

Genedrive plc attracted renewed buying interest after its shares climbed4.76%during trading on16 July 2026.

Ankur Sharma | 16 July 2026

LSE:OBD Share Price Slides as Investors Assess Funding Outlook and Commercial Growth

Oxford BioDynamics came under renewed selling pressure during Thursday's session as investors continued evaluating the company's financial position following its recently published interim results.

Ankur Sharma | 16 July 2026

Abingdon Health Shares Gain Ground: Why Is ABDX Stock Attracting Investor Attention?

• ABDX shares gained 2.56% on 16 July 2026, closing at 10.00 GBX.• Abingdon Health plc has a market capitalization of approximately 24.64 million GBP, placing it in the micro-cap segment.• The company develops and manufactures rapid diagnostic testing technologies, including lateral flow solutions.• …

Ankur Sharma | 16 July 2026

Cambridge Cognition Shares Jump: Why Is COG Stock Gaining Momentum?

• COG shares gained 4.71% on 16 July 2026, closing at 32.99 GBX.• Cambridge Cognition Holdings Plc has a market capitalization of approximately 17.02 million GBP, placing it in the micro-cap segment.• The company develops digital cognitive assessment technologies used in clinical trials and …

Ankur Sharma | 16 July 2026

ImmuPharma Shares Jump: Why Is IMM Stock Climbing in July 2026?

• IMM shares gained 5.11% on 16 July 2026, closing at 3.89 GBX.• ImmuPharma PLC has a market capitalization of approximately 23.08 million GBP, placing it in the micro-cap segment.• The company develops therapeutic candidates focused on autoimmune and inflammatory diseases.• Clinical development, regulatory …

Ankur Sharma | 16 July 2026

AstraZeneca's $80bn Bet: Science, China and America All Have to Deliver at Once

AstraZeneca has built out a wide oncology portfolio — antibody-drug conjugates and targeted therapies developed alone and with partners — alongside respiratory, cardiovascular and rare-disease franchises strengthened by the Alexion acquisition. FY2025 results, published February 2026, highlighted a run of positive late-stage trial readouts …

Ishan Mudgal | 15 July 2026

PureTech Health Just Simplified Its Listing While Complicating Its Portfolio — Here's Why

PureTech identifies scientific advances, builds development programmes around them, and either advances them in-house or seeds them into separately capitalised 'Founded Entities.' The signature success remains Karuna Therapeutics — Bristol Myers Squibb completed its $14bn acquisition of Karuna in March 2024, and the underlying …

Ishan Mudgal | 15 July 2026

RUA Life Sciences Turned EBITDA Positive — By Spinning Out Its Most Exciting Programme

Three activities: contract design and manufacture of implantable and long-term medical devices through RUA Medical (roughly 86% of group revenue); licensing of proprietary Elast-Eon biostable polyurethane through RUA Biomaterials; and development of its own implantable technologies, principally structural heart and vascular. Following the September …

Ishan Mudgal | 15 July 2026
Support

Hi! How can we help you today?

Loading…